Dr. Schwartz, a board-certified gastroenterologist, has experience with more than 1,000 clinical trials in various specialties.
“Dr. Schwartz brings to the company a unique combination of medical practice and relevant commercial experience relating to specialty biologics that will add depth of knowledge to what is already a best-in-class contract commercial operations team,” said Stephen Cichy, founder and managing director of Monarch.
More articles on gastroenterology:
Dr. John Mitchell elected to BCBS of Nebraska board
Avantis Medical Systems submits 510(k) application for colonoscopy device
New guidelines suggest CRC patients undergo postoperative colonoscopy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
